MedTrace Logo

Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients

NCT03348683 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2020-01-07

Study results available
· View outcomes & findings →

Summary

A randomized, prospective trial will be offered to women admitted to the labor floors at Mount Sinai Medical Center for labor induction.

Conditions

  • Induction of Labor Affected Fetus / Newborn

Interventions

DRUG

Propranolol

After induction is started with Foley or misoprostol placement, 30 minutes will pass before administration of the one-time study medication, IV Propanolol.

DRUG

Placebo

After induction is started with Foley or misoprostol placement, 30 minutes will pass before administration of IV Saline

Sponsors & Collaborators

Principal Investigators

  • Joanne Stone, MD, MS · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-11
Primary Completion
2018-12-11
Completion
2018-12-11
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03348683 on ClinicalTrials.gov